APOA1 and Alzheimer disease: The present study first revealed the association of -250 G/A variants with plasma lipids in AD patients in the Chinese population, only finding an significant effect on serum apoA-I levels, which was higher in the subjects carrying A allele or AA genotype than other genotypes or alleles carriers in total subjects and the control group.